📰 Functional Assessment News
Functional Assessment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Functional Assessment. Real-time updates on events, politics, business and more.
June 7, 2024
A lower FACIT-Fatigue score, indicating higher fatigue was independently associated with female sex, a high BMI, a high stress level, and poor sleep quality.
May 22, 2024
Available for interview on breaking news, trending topics in respiratory medicine
May 20, 2024
Patients with high-risk early-stage non-small cell lung cancer who underwent surgery reported similar quality of life outcomes as those who had radiation.
April 28, 2024
Patients with RA reported worse outcomes for all PROMs compared with CSA or UA.
April 24, 2024
Melatonin showed no benefit for cancer-related fatigue or other symptoms in women with early-stage breast cancer receiving radiotherapy treatment.
April 24, 2024
Iptocopan demonstrated superiority when treating patients with immunoglobulin A nephropathy and is the first drug to specifically target the alternative complement pathway.
April 18, 2024
A single question can be used to predict early treatment discontinuation in patients with multiple myeloma, a study suggests. A single question can be used to predict early treatment discontinuation in patients with multiple myeloma, a study suggests.
April 2, 2024
AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment.
April 2, 2024
A9026i FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or...
April 1, 2024
The approval was based on data from the phase 3 ALPHA trial, which evaluated danicopan as add-on therapy to ravulizumab or eculizumab in adults with PNH and clinically significant EVH.